COVID - 19 Vaccination Update - Day 460 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 20 APR 2022 8:10PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 187 Crore (1,87,05,29,035) today. More than 13 lakh (13,69,541) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10404547
	2^nd Dose	10010165
	Precaution Dose	4644513
FLWs	1^st Dose	18414621
	2^nd Dose	17528968
	Precaution Dose	7235722
Age Group 12-14 years	1^st Dose	25342777
	2^nd Dose	1219892
Age Group 15-18 years	1^st Dose	58001822
	2^nd Dose	40859046
Age Group 18-44 years	1^st Dose	555374166
	2^nd Dose	474093907
	Precaution Dose	51688
Age Group 45-59 years	1^st Dose	202867715
	2^nd Dose	187082480
	Precaution Dose	184098
Over 60 years	1^st Dose	126827265
	2^nd Dose	116540116
	Precaution Dose	13845527
Cumulative 1^st dose administered		997232913
Cumulative 2^nd dose administered		847334574
Precaution Dose		25961548
Total		1870529035

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 20^th April, 2022 (460^th Day)
HCWs	1^st Dose	56
	2^nd Dose	488
	Precaution Dose	13454
FLWs	1^st Dose	95
	2^nd Dose	882
	Precaution Dose	30892
Age Group 12-14 years	1^st Dose	237827
	2^nd Dose	341133
Age Group 15-18 years	1^st Dose	29174
	2^nd Dose	105213
Age Group 18-44 years	1^st Dose	28267
	2^nd Dose	329623
	Precaution Dose	4628
Age Group 45-59 years	1^st Dose	4016
	2^nd Dose	69012
	Precaution Dose	19831
Over 60 years	1^st Dose	3102
	2^nd Dose	45120
	Precaution Dose	106728
Cumulative 1^st dose administered		302537
Cumulative 2^nd dose administered		891471
Precaution Dose		175533
Total		1369541

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.